Cidara drops 5% despite 'positive' Phase 3 rezafungin data in candidemia/invasive candidiasis
December 14 2021 - 7:05AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2024 to May 2024
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From May 2023 to May 2024